Holocene Renewable Energy Fund 3, LLC
Rubric Capital Management LP, a New York-based investment management firm, has reported an ownership change in Mereo BioPharma Group plc, a publicly traded biopharmaceutical company. Rubric Capital Management LP now holds 82,272,810 Ordinary Shares, representing approximately 14.07% of the class.
Mereo BioPharma Group plc, listed on the NASDAQ Global Market under the symbol MREO, is a biopharmaceutical company focused on the development and commercialization of innovative therapies for rare diseases. With a diverse pipeline of potential treatments, Mereo BioPharma aims to address unmet medical needs and improve the lives of patients worldwide.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
